stocktools
Offerings // Sunshine Biopharma Inc.

SBFMW offering history

Every offering-related filing in Sunshine Biopharma Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 428 filings back to May 25, 2007.

Last executed offering
Oct 9, 2026
424B4 — priced deal (shares or notes)
Last registration (announced)
Oct 2, 2026
S-1 — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
3
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 9, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Oct 7, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 2, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 8, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 8, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 28, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 20, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 19, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
May 18, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 12, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Aug 12, 2025RW →WITHDRAWNRegistration withdrawn
Aug 12, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 12, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 5, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 3, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 15, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 6, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2024424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Nov 8, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 6, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 14, 2024424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 12, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 9, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 1, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 5, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 5, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 25, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 16, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 20, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 20, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 20, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 10, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 28, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 8, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 8, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 30, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 15, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 17, 2022424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 14, 2022S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 14, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
SBFMW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SBFMW workspace →
SBFMW offering FAQ

When did SBFMW last execute an offering?

Per SEC filings, Sunshine Biopharma Inc.'s most recent priced offering document is a 424B4 filed 2026-10-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SBFMW last announce or register an offering?

The most recent registration is a S-1 filed 2026-10-02. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.